Drugs / U3-1784
last change Feb 2017 re-read 2 minutes ago

U3-1784

Developed for
hepatocellular carcinoma
Investigated by
Daiichi Sankyo

Trials 1 · a red edge is where a trial was stopped

20162017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02690350 Feb 2016 → Feb 2017 hepatocellular carcinoma Daiichi Sankyo Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as U3-1784 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02690350